Periodontal diseases belong to the most common chronic disorders affecting mankind. Smoking and impaired plasminogen activation with hypercoagulation and fibrinolysis inhibition have been proposed as having a role in predisposition to these diseases. We investigated relationships among adult periodontitis, smoking, and a variation in the deletion/insertion (4G/5G) promoter polymorphism of the plasminogen-activator-inhibitor-1 (PAI-1) gene in 304 Caucasian subjects. An association was detected between the deletion (4G) allele (and 4G/4G genotype) 
Introduction
Periodontal diseases are among the most common chronic disorders and approximately 30% of adults in Europe are affected. 1 Interest in risk assessment for these diseases came from the observation that periodontitis not only impairs the general state of health (loss of the teeth), but also appears to have a relationship with cardiovascular and cerebrovascular diseases. 2 There is evidence that the interindividual variability in this condition depends on environmental (poor hygiene of oral cavity, smoking etc) 3, 4 and genetic factors, most of which are not yet identified. 5 In periodontitis patients, similarly as in cardiovascular diseases, abnormal regulation in the coagulation and fibrinolytic systems play an important role. [6] [7] [8] Plasminogen-activator-inhibitor-1 (PAI-1), a member of the SERPIN family, is the main inhibitor of tissue-and urokinase-type plasminogen activators and one of the major determinants of fibrinolysis. 9 This protein is an acutephase reactant; its concentrations are increased by inflammatory stimuli such as interleukin-1␤ and tumor necrosis factor. 10 PAI-1 than those with one or two copies of the 5G allele; 10 the 5G allele is characterized by a lower transcriptional rate of the PAI-1 gene because of binding a transcriptional repressor protein which cannot be bound by the 4G allele. 10, 12 Since the 4G allele of the 4G/5G promoter polymorphism of the PAI-1 gene and/or smoking have been previously associated with increased plasma levels and activity of PAI, 13, 14 we investigated the role of this polymorphism in the pathogenesis of adult periodontitis with regard to smoking status.
Results
The distribution of PAI-1 alleles and genotypes in the patients with adult periodontitis (4G allele: 0.642 4G/4G genotype: 44%) were significantly different from the distributions seen in the 188 healthy individuals (4G allele: 0.521 4G/4G genotype: 28.2%) (P = 0.0022 (P corr Ͻ 0.01), P = 0.014, (P corr Ͻ 0.05) respectively, Table 1 ). Because smoking is a known risk factor for periodontitis, nonsmoking and smoking subjects were analysed separately. Interestingly, when only the non-smoking subjects were included in the analysis, differences between the allelic and genotype frequencies of the 4G/5G polymorphism in the adult periodontitis patients and normal population became highly significant (P = 0.00021 (P corr Ͻ 0.01), P = 0.0024, (P corr Ͻ 0.05), respectively, Table 1 ). No significant differences were detected in the allelic and genotype distributions between smoking periodontitis patients and smoking controls (P = NS, P = NS, respectively). As shown in Table 2 , the 4G/4G genotype (with the highest PAI-1 levels) 10 was examined in relation to susceptibility to adult periodontitis and compared with the two other genotypes. We found statistically significant differences in the distribution of this genotype between patients and control subjects (and also in the subgroup of nonsmoking patients vs non-smoking controls (odds ratio (OR) = 2.0; 95% CI: 1.23-3.25, P = 0.0037 (P corr Ͻ 0.01); OR = 2.53, 95% CI: 1.41-4.53, P = 0.0014 (P corr Ͻ 0.01), respectively, Table 2 ). When the whole sample of the control subjects was analysed according to the PAI-1 4G/5G polymorphism, there was no difference with respect to cigarette smoking (non-smoking controls (68.1% subjects): 4G allele = 0.539, smoking controls (31.9% subjects): 4G allele = 0.483 P = NS). In contrast, allele and genotype frequencies varied significantly between nonsmoking and smoking patients with adult periodontitis (non-smoking (67.2%): 4G allele = 0.718, smoking (32.8%): 4G allele = 0.487; P = 0.0005 (P corr Ͻ 0.01), P = 0.0045 (P corr Ͻ 0.05), respectively).
Discussion
Patients with periodontitis were found to have alterations in the blood coagulation system associated with hypercoagulation and fibrinolysis inhibition and a reduced antiaggregation activity in periodontal tissues. Increased levels of the plasminogen-activator-inhibitors were previously detected in inflammed gingival and periodontal tissues. 15, 16 Our study showed a significant association between the carriage of the allele 4G (deletion) polymorGenes and Immunity phism in the PAI-1 gene and adult periodontitis in the Czech population. It has been suggested that this single base-pair polymorphism 675-bp upstream from the start of transcription is functionally important in regulating the expression of the PAI-1 gene and the 4G allele has been associated with increased PAI-1 activity. 10, 17 Also chronic smoking has been associated with impaired fibrinolysis in plasma and this largely reflected elevated plasma PAI-1 in smokers.
14 It is interesting that the genetic association of the functional promoter polymorphism in the PAI-1 gene with periodontitis in our study was observed only in the group of non-smokers. The impairment of the fibrinolytic mechanisms in smokers may occur as a consequence of smoking which is known to increase the levels of PAI-1, thus possibly masking the influence of individual variants of the PAI-1 polymorphism. Our finding that a polymorphism which determines the expression of an inhibitor of the fibrinolytic pathway is significantly related to adult periodontitis may seem surprising. However, there is evidence that the activation of coagulation and inflammation are closely related and mutually interdependent and in primitive species, there is a single pathway for both coagulation and inflammation. 18 The genetic basis for periodontal disease (as for many other diseases with multifactorial pathogenesis) is influenced by phenotypic variations caused by the common alleles of polymorphic genes (and their combinations) relevant to the disease etiopathogenesis. There is strong evidence for a key role of pro-inflammatory cytokines and growth factors (eg interleukin-1, tumour necrosis factor, transforming growth factor) 19, 20 and other pluripotent factors cooperating during inflammatory reactions (eg endothelin, ACE). 21 However, the PAI-1 genotype identified here appears to be a marker of some biological change that is sufficiently strong to lead to severe adult periodontitis in the absence of smoking.
Materials and methods

Study population
Caucasian subjects of Czech nationality (n = 304) were included in this study. Phenotype status was assigned without knowledge of genotypes by two investigators independently. A total of 116 consecutive patients with moderate to severe adult periodontitis (59 men and 57 women, age 39.6 ± 7.8 years (mean ± s.d.), range: 20-54 years) from the Department of Periodontology of the Clinic of Stomatology were studied. Subjects were screened by means of WHO probes and CPITN (Community Periodontal Index of Treatment Needs). 22 All our patients fulfilling the diagnostic criteria for adult periodontitis defined by The American Academy of Periodontology formed the adult periodontitis cohort. 23 The diagnosis was based on physical examination, medical and dental history, probing depth, assessment of attachment loss, tooth mobility and bone loss according radiographs. Criteria for inclusion of patients were described previously. 19, 21 The referent population consisted of 188 unrelated randomly selected Caucasian subjects (97 men and 91 women, age 37.9 ± 9.9 years) residing in the same geographic area as the patients studied. All patients were in good health apart from their periodontal disease (they had no evidence of cardiovascular disorders-especially cardiovascular disease and hypertension, diabetes mellitus or allergy); healthy controls had no evidence of cardiovascular or cerebrovascular disease or thrombosis. In order to adjust for the effect of smoking history on periodontal disease, the subjects were classified in two groups: those who had never smoked (referred to as nonsmokers) and those who were current smokers or former smokers for у5 pack years (referred to as smokers). The study was performed with the approval of the Ethics Committee of the Medical Faculty, Masaryk University, Brno. All the subjects gave written informed consent to participation in this study.
Genotype identificaton
Genomic DNA was extracted from peripheral blood leukocytes and used as a template for polymerase chain reaction (PCR). Detection of the PAI-1 4G/5G promoter polymorphism was carried out with allele-specific PCR as described previously.
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Statistical evaluation
All statistical analyses were performed using the programme package Statistica v. 3.0 (StatSoft Inc Tulsa, USA). The 2 test and Fisher's exact test were performed to test for a comparison of differences in genotype or allele frequencies among groups. Corrections for multiple comparisons were performed by Holm's method. Odds ratio, confidence intervals, and significance values were calculated.
